Loading...

Cameron Carter

TitleVC RSCH
InstitutionUniversity of California Davis
DepartmentMED:PSYCHIATRY & BEHAV SCI
Address540 Mrak Hall
CA 95616
Phone530-754-7764
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter C, Ashwood P. Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation. 2018 May 26; 15(1):165. PMID: 29803226.
      View in: PubMed
    2. Smucny J, Lesh TA, Iosif AM, Niendam TA, Tully LM, Carter C. Longitudinal stability of cognitive control in early psychosis: Nondegenerative deficits across diagnoses. J Abnorm Psychol. 2018 May 21. PMID: 29781657.
      View in: PubMed
    3. Carter C. Clusters, Dimensions, and Hierarchies: Finding a Path Forward for the Neuroscience of Mental Disorders? Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jan; 3(1):2-3. PMID: 29397075.
      View in: PubMed
    4. Scangos KW, Carter C, Gurkoff G, Zhang L, Shahlaie K. A pilot study of subthalamic theta frequency deep brain stimulation for cognitive dysfunction in Parkinson's disease. Brain Stimul. 2018 Mar - Apr; 11(2):456-458. PMID: 29203130.
      View in: PubMed
    5. Carrión RE, Walder DJ, Auther AM, McLaughlin D, Zyla HO, Adelsheim S, Calkins R, Carter C, McFarland B, Melton R, Niendam T, Ragland JD, Sale TG, Taylor SF, McFarlane WR, Cornblatt BA. From the psychosis prodrome to the first-episode of psychosis: No evidence of a cognitive decline. J Psychiatr Res. 2018 Jan; 96:231-238. PMID: 29121595.
      View in: PubMed
    6. Smucny J, Lesh TA, Newton K, Niendam TA, Ragland JD, Carter C. Levels of Cognitive Control: A Functional Magnetic Resonance Imaging-Based Test of an RDoC Domain Across Bipolar Disorder and Schizophrenia. Neuropsychopharmacology. 2018 Feb; 43(3):598-606. PMID: 28948978.
      View in: PubMed
    7. Ray KL, Lesh TA, Howell AM, Salo TP, Ragland JD, MacDonald AW, Gold JM, Silverstein SM, Barch DM, Carter C. Functional network changes and cognitive control in schizophrenia. Neuroimage Clin. 2017; 15:161-170. PMID: 28529872.
      View in: PubMed
    8. Boudewyn MA, Carter C. Electrophysiological correlates of adaptive control and attentional engagement in patients with first episode schizophrenia and healthy young adults. Psychophysiology. 2018 Mar; 55(3). PMID: 28295391.
      View in: PubMed
    9. Greenland-White SE, Ragland JD, Niendam TA, Ferrer E, Carter C. Episodic memory functions in first episode psychosis and clinical high risk individuals. Schizophr Res. 2017 Oct; 188:151-157. PMID: 28143678.
      View in: PubMed
    10. Boudewyn MA, Carter C, Long DL, Traxler MJ, Lesh TA, Mangun GR, Swaab TY. Language context processing deficits in schizophrenia: The role of attentional engagement. Neuropsychologia. 2017 02; 96:262-273. PMID: 28126626.
      View in: PubMed
    11. Carter C, Bearden CE, Bullmore ET, Geschwind DH, Glahn DC, Gur RE, Meyer-Lindenberg A, Weinberger DR. Enhancing the Informativeness and Replicability of Imaging Genomics Studies. Biol Psychiatry. 2017 Aug 01; 82(3):157-164. PMID: 27793332.
      View in: PubMed
    12. Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AFT, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter C, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA, Zubieta JK. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biol Psychiatry. 2016 07 15; 80(2):84-86. PMID: 27346079.
      View in: PubMed
    13. Krystal JH, Abi-Dargham A, Barch DM, Bullmore ET, Carter C, Geschwind DH, Harrison PJ, Nestler EJ, Stein MB. Biological Psychiatry and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Adopt Neuroscience-Based Nomenclature. Biol Psychiatry. 2016 07 01; 80(1):2-3. PMID: 27312230.
      View in: PubMed
    14. Carrión RE, Cornblatt BA, Burton CZ, Tso IF, Auther AM, Adelsheim S, Calkins R, Carter C, Niendam T, Sale TG, Taylor SF, McFarlane WR. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project. Am J Psychiatry. 2016 Oct 01; 173(10):989-996. PMID: 27363511.
      View in: PubMed
    15. Krystal JH, Abi-Dargham A, Barch DM, Bullmore ET, Carter C, Geschwind DH, Harrison PJ, Nestler EJ, Stein MB. Biological Psychiatry and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Adopt Neuroscience-Based Nomenclature. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jul; 1(4):300-301. PMID: 29560862.
      View in: PubMed
    16. Solomon M, McCauley JB, Iosif AM, Carter C, Ragland JD. Cognitive control and episodic memory in adolescents with autism spectrum disorders. Neuropsychologia. 2016 08; 89:31-41. PMID: 27184119.
      View in: PubMed
    17. Barch DM, Carter C. Functional and Structural Brain Connectivity in Psychopathology. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 May; 1(3):196-198. PMID: 29560879.
      View in: PubMed
    18. Minzenberg MJ, Lesh TA, Niendam TA, Cheng Y, Carter C. Conflict-Related Anterior Cingulate Functional Connectivity Is Associated With Past Suicidal Ideation and Behavior in Recent-Onset Psychotic Major Mood Disorders. J Neuropsychiatry Clin Neurosci. 2016 Apr 08; appineuropsych15120422. PMID: 27056021.
      View in: PubMed
    19. Carter C, Lesh TA, Barch DM. Thresholds, Power, and Sample Sizes in Clinical Neuroimaging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar; 1(2):99-100. PMID: 29560877.
      View in: PubMed
    20. Lynch S, McFarlane WR, Joly B, Adelsheim S, Auther A, Cornblatt BA, Migliorati M, Ragland JD, Sale T, Spring E, Calkins R, Carter C, Jaynes R, Taylor SF, Downing D. Early Detection, Intervention and Prevention of Psychosis Program: Community Outreach and Early Identification at Six U.S. Sites. Psychiatr Serv. 2016 05 01; 67(5):510-6. PMID: 26766751.
      View in: PubMed
    21. Carter C. As the Field Matures … We Begin. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan; 1(1):3-4. PMID: 29560893.
      View in: PubMed
    22. Ragland JD, Ranganath C, Phillips J, Boudewyn MA, Kring AM, Lesh TA, Long DL, Luck SJ, Niendam TA, Solomon M, Swaab TY, Carter C. Cognitive Control of Episodic Memory in Schizophrenia: Differential Role of Dorsolateral and Ventrolateral Prefrontal Cortex. Front Hum Neurosci. 2015; 9:604. PMID: 26617507; PMCID: PMC4639631.
    23. Phillips RC, Salo T, Carter C. Distinct neural correlates for attention lapses in patients with schizophrenia and healthy participants. Front Hum Neurosci. 2015; 9:502. PMID: 26500517; PMCID: PMC4594500.
    24. Minzenberg MJ, Lesh TA, Niendam TA, Yoon JH, Cheng Y, Rhoades RN, Carter C. Control-related frontal-striatal function is associated with past suicidal ideation and behavior in patients with recent-onset psychotic major mood disorders. J Affect Disord. 2015 Dec 01; 188:202-9. PMID: 26363618.
      View in: PubMed
    25. Solomon M, Ragland JD, Niendam TA, Lesh TA, Beck JS, Matter JC, Frank MJ, Carter C. Atypical Learning in Autism Spectrum Disorders: A Functional Magnetic Resonance Imaging Study of Transitive Inference. J Am Acad Child Adolesc Psychiatry. 2015 Nov; 54(11):947-55. PMID: 26506585; PMCID: PMC4624100 [Available on 11/01/16].
    26. Minzenberg MJ, Yoon JH, Cheng Y, Carter C. Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia. Neuropsychopharmacology. 2016 Apr; 41(5):1231-40. PMID: 26329382; PMCID: PMC4793107 [Available on 04/01/17].
    27. Carter C. Expanding the Reach of Biological Psychiatry with Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. Biol Psychiatry. 2015 Oct 01; 78(7):434-5. PMID: 26300271.
      View in: PubMed
    28. Carter C. Rectifying disordered brain dynamics to improve cognition in schizophrenia. Proc Natl Acad Sci U S A. 2015 Jul 28; 112(30):9152-3. PMID: 26157137; PMCID: PMC4522772.
    29. Silverstein SM, Harms MP, Carter C, Gold JM, Keane BP, MacDonald A, Ragland JD, Barch DM. Cortical contributions to impaired contour integration in schizophrenia. Neuropsychologia. 2015 Aug; 75:469-80. PMID: 26160288; PMCID: PMC4546547.
    30. Krystal JH, Carter C. Introducing a new journal: Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. Biol Psychiatry. 2015 Jun 01; 77(11):922. PMID: 25959562.
      View in: PubMed
    31. Minzenberg MJ, Lesh T, Niendam T, Yoon JH, Cheng Y, Rhoades R, Carter C. Conflict-related anterior cingulate functional connectivity is associated with past suicidal ideation and behavior in recent-onset schizophrenia. J Psychiatr Res. 2015 Jun; 65:95-101. PMID: 25891474.
      View in: PubMed
    32. Kappenman ES, Luck SJ, Kring AM, Lesh TA, Mangun GR, Niendam T, Ragland JD, Ranganath C, Solomon M, Swaab TY, Carter C. Electrophysiological Evidence for Impaired Control of Motor Output in Schizophrenia. Cereb Cortex. 2016 May; 26(5):1891-9. PMID: 25618891.
      View in: PubMed
    33. Poppe AB, Carter C, Minzenberg MJ, MacDonald AW. Task-based functional connectivity as an indicator of genetic liability to schizophrenia. Schizophr Res. 2015 Mar; 162(1-3):118-23. PMID: 25592803.
      View in: PubMed
    34. Solomon M, Frank MJ, Ragland JD, Smith AC, Niendam TA, Lesh TA, Grayson DS, Beck JS, Matter JC, Carter C. Feedback-driven trial-by-trial learning in autism spectrum disorders. Am J Psychiatry. 2015 Feb 01; 172(2):173-81. PMID: 25158242.
      View in: PubMed
    35. Minzenberg MJ, Yoon JH, Cheng Y, Carter C. Modafinil effects on middle-frequency oscillatory power during rule selection in schizophrenia. Neuropsychopharmacology. 2014 Dec; 39(13):3018-26. PMID: 24964814; PMCID: PMC4229573.
    36. Minzenberg MJ, Lesh TA, Niendam TA, Yoon JH, Rhoades RN, Carter C. Frontal cortex control dysfunction related to long-term suicide risk in recent-onset schizophrenia. Schizophr Res. 2014 Aug; 157(1-3):19-25. PMID: 24972755.
      View in: PubMed
    37. Fassbender C, Scangos K, Lesh TA, Carter C. RT distributional analysis of cognitive-control-related brain activity in first-episode schizophrenia. Cogn Affect Behav Neurosci. 2014 Mar; 14(1):175-88. PMID: 24615691; PMCID: PMC4063412.
    38. Carter C, Bullmore ET, Harrison P. Is there a flame in the brain in psychosis? Biol Psychiatry. 2014 Feb 15; 75(4):258-9. PMID: 24439553.
      View in: PubMed
    39. Minzenberg MJ, Gomes GC, Yoon JH, Swaab TY, Carter C. Disrupted action monitoring in recent-onset psychosis patients with schizophrenia and bipolar disorder. Psychiatry Res. 2014 Jan 30; 221(1):114-21. PMID: 24314907; PMCID: PMC4019327.
    40. Solomon M, Yoon JH, Ragland JD, Niendam TA, Lesh TA, Fairbrother W, Carter C. The development of the neural substrates of cognitive control in adolescents with autism spectrum disorders. Biol Psychiatry. 2014 Sep 01; 76(5):412-21. PMID: 24209777; PMCID: PMC3999330.
    41. Niendam TA, Lesh TA, Yoon J, Westphal AJ, Hutchison N, Daniel Ragland J, Solomon M, Minzenberg M, Carter C. Impaired context processing as a potential marker of psychosis risk state. Psychiatry Res. 2014 Jan 30; 221(1):13-20. PMID: 24120302; PMCID: PMC3947990.
    42. Moore H, Geyer MA, Carter C, Barch DM. Harnessing cognitive neuroscience to develop new treatments for improving cognition in schizophrenia: CNTRICS selected cognitive paradigms for animal models. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt B):2087-91. PMID: 24090823; PMCID: PMC3965347.
    43. Salo R, Fassbender C, Iosif AM, Ursu S, Leamon MH, Carter C. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure. Psychiatry Res. 2013 Dec 15; 210(2):529-35. PMID: 23896355; PMCID: PMC3818411.
    44. Paz-Alonso PM, Ghetti S, Ramsay I, Solomon M, Yoon J, Carter C, Ragland JD. Semantic processes leading to true and false memory formation in schizophrenia. Schizophr Res. 2013 Jul; 147(2-3):320-5. PMID: 23623175; PMCID: PMC3679292.
    45. Yoon JH, Minzenberg MJ, Raouf S, D'Esposito M, Carter C. Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol Psychiatry. 2013 Jul 15; 74(2):122-9. PMID: 23290498; PMCID: PMC3620727.
    46. Carter C. Neuroeconomics: sharpened tools of value for clinical cognitive and affective neuroscience. Biol Psychiatry. 2012 Jul 15; 72(2):82-3. PMID: 22727457.
      View in: PubMed
    47. Niendam TA, Laird AR, Ray KL, Dean YM, Glahn DC, Carter C. Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions. Cogn Affect Behav Neurosci. 2012 Jun; 12(2):241-68. PMID: 22282036; PMCID: PMC3660731.
    48. Minzenberg MJ, Yoon JH, Soosman SK, Carter C. Excessive contralateral motor overflow in schizophrenia measured by fMRI. Psychiatry Res. 2012 Apr 30; 202(1):38-45. PMID: 22608155.
      View in: PubMed
    49. Boudewyn MA, Carter C, Swaab TY. Cognitive control and discourse comprehension in schizophrenia. Schizophr Res Treatment. 2012; 2012:484502. PMID: 22970364; PMCID: PMC3420642.
    50. Yoon JH, Nguyen DV, McVay LM, Deramo P, Minzenberg MJ, Ragland JD, Niendham T, Solomon M, Carter C. Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia. Schizophr Res. 2012 Mar; 135(1-3):28-33. PMID: 22277668; PMCID: PMC3288252.
    51. Solomon M, Miller M, Taylor SL, Hinshaw SP, Carter C. Autism symptoms and internalizing psychopathology in girls and boys with autism spectrum disorders. J Autism Dev Disord. 2012 Jan; 42(1):48-59. PMID: 21442362; PMCID: PMC3244604.
    52. Minzenberg MJ, Carter C. Developing treatments for impaired cognition in schizophrenia. Trends Cogn Sci. 2012 Jan; 16(1):35-42. PMID: 22178120.
      View in: PubMed
    53. Ragland JD, Ranganath C, Barch DM, Gold JM, Haley B, MacDonald AW, Silverstein SM, Strauss ME, Yonelinas AP, Carter C. Relational and Item-Specific Encoding (RISE): task development and psychometric characteristics. Schizophr Bull. 2012 Jan; 38(1):114-24. PMID: 22124089; PMCID: PMC3245591.
    54. Carter C, Minzenberg M, West R, Macdonald A. CNTRICS imaging biomarker selections: Executive control paradigms. Schizophr Bull. 2012 Jan; 38(1):34-42. PMID: 22114099; PMCID: PMC3245594.
    55. Carter C, Barch DM. Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development. Schizophr Bull. 2012 Jan; 38(1):26-33. PMID: 21914642; PMCID: PMC3245593.
    56. Ragland JD, Blumenfeld RS, Ramsay IS, Yonelinas A, Yoon J, Solomon M, Carter C, Ranganath C. Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia. Neuroimage. 2012 Jan 16; 59(2):1719-26. PMID: 21907293; PMCID: PMC3230711.
    57. Carter C, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biol Psychiatry. 2011 Jul 01; 70(1):7-12. PMID: 21529781; PMCID: PMC3116022.
    58. Fornito A, Yoon J, Zalesky A, Bullmore ET, Carter C. General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry. 2011 Jul 01; 70(1):64-72. PMID: 21514570; PMCID: PMC4015465.
    59. Mayda AB, Westphal A, Carter C, DeCarli C. Late life cognitive control deficits are accentuated by white matter disease burden. Brain. 2011 Jun; 134(Pt 6):1673-83. PMID: 21482547; PMCID: PMC3102238.
    60. Ursu S, Kring AM, Gard MG, Minzenberg MJ, Yoon JH, Ragland JD, Solomon M, Carter C. Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. Am J Psychiatry. 2011 Mar; 168(3):276-85. PMID: 21205806; PMCID: PMC4019338.
    61. Minzenberg MJ, Yoon JH, Carter C. Modafinil modulation of the default mode network. Psychopharmacology (Berl). 2011 May; 215(1):23-31. PMID: 21153806; PMCID: PMC3072511.
    62. Walsh BJ, Buonocore MH, Carter C, Mangun GR. Integrating conflict detection and attentional control mechanisms. J Cogn Neurosci. 2011 Sep; 23(9):2211-21. PMID: 21126158; PMCID: PMC3142580.
    63. Lesh TA, Niendam TA, Minzenberg MJ, Carter C. Cognitive control deficits in schizophrenia: mechanisms and meaning. Neuropsychopharmacology. 2011 Jan; 36(1):316-38. PMID: 20844478; PMCID: PMC3052853.
    64. Minzenberg MJ, Firl AJ, Yoon JH, Gomes GC, Reinking C, Carter C. Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology. 2010 Dec; 35(13):2590-9. PMID: 20827271; PMCID: PMC3055567.
    65. Yoon JH, Maddock RJ, Rokem A, Silver MA, Minzenberg MJ, Ragland JD, Carter C. GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci. 2010 Mar 10; 30(10):3777-81. PMID: 20220012; PMCID: PMC2846788.
    66. Stoddard J, Niendam T, Hendren R, Carter C, Simon TJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res. 2010 May; 118(1-3):118-21. PMID: 20056393; PMCID: PMC2856801.
    67. Minzenberg MM, Carter C. The neurochemistry of rule use. Biol Psychiatry. 2009 Aug 15; 66(4):306. PMID: 19643217.
      View in: PubMed
    68. Corbett BA, Carmean V, Ravizza S, Wendelken C, Henry ML, Carter C, Rivera SM. A functional and structural study of emotion and face processing in children with autism. Psychiatry Res. 2009 Sep 30; 173(3):196-205. PMID: 19665877; PMCID: PMC2748131.
    69. Yoon JH, Rokem AS, Silver MA, Minzenberg MJ, Ursu S, Ragland JD, Carter C. Diminished orientation-specific surround suppression of visual processing in schizophrenia. Schizophr Bull. 2009 Nov; 35(6):1078-84. PMID: 19620601; PMCID: PMC2762622.
    70. Solomon M, Ozonoff SJ, Ursu S, Ravizza S, Cummings N, Ly S, Carter C. The neural substrates of cognitive control deficits in autism spectrum disorders. Neuropsychologia. 2009 Oct; 47(12):2515-26. PMID: 19410583; PMCID: PMC2766616.
    71. Ursu S, Carter C. An initial investigation of the orbitofrontal cortex hyperactivity in obsessive-compulsive disorder: exaggerated representations of anticipated aversive events? Neuropsychologia. 2009 Aug; 47(10):2145-8. PMID: 19467363; PMCID: PMC2688401.
    72. Bhangoo RK, Carter C. Very early interventions in psychotic disorders. Psychiatr Clin North Am. 2009 Mar; 32(1):81-94. PMID: 19248918.
      View in: PubMed
    73. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter C. Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science. 2008 Dec 12; 322(5908):1700-2. PMID: 19074351.
      View in: PubMed
    74. Carter C, Barch DM, Gur R, Gur R, Pinkham A, Ochsner K. CNTRICS final task selection: social cognitive and affective neuroscience-based measures. Schizophr Bull. 2009 Jan; 35(1):153-62. PMID: 19011231; PMCID: PMC2643972.
    75. Ursu S, Clark KA, Aizenstein HJ, Stenger VA, Carter C. Conflict-related activity in the caudal anterior cingulate cortex in the absence of awareness. Biol Psychol. 2009 Mar; 80(3):279-86. PMID: 19026710; PMCID: PMC2679390.
    76. Yoon JH, Tamir D, Minzenberg MJ, Ragland JD, Ursu S, Carter C. Multivariate pattern analysis of functional magnetic resonance imaging data reveals deficits in distributed representations in schizophrenia. Biol Psychiatry. 2008 Dec 15; 64(12):1035-41. PMID: 18822407; PMCID: PMC2772995.
    77. Carter C, Heckers S, Nichols T, Pine DS, Strother S. Optimizing the design and analysis of clinical functional magnetic resonance imaging research studies. Biol Psychiatry. 2008 Nov 15; 64(10):842-9. PMID: 18718572.
      View in: PubMed
    78. Yoon JH, Minzenberg MJ, Ursu S, Ryan Walter BS, Walters R, Wendelken C, Ragland JD, Carter C. Association of dorsolateral prefrontal cortex dysfunction with disrupted coordinated brain activity in schizophrenia: relationship with impaired cognition, behavioral disorganization, and global function. Am J Psychiatry. 2008 Aug; 165(8):1006-14. PMID: 18519527; PMCID: PMC3985422.
    79. Carter C, Barch DM, Buchanan RW, Bullmore E, Krystal JH, Cohen J, Geyer M, Green M, Nuechterlein KH, Robbins T, Silverstein S, Smith EE, Strauss M, Wykes T, Heinssen R. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry. 2008 Jul 01; 64(1):4-10. PMID: 18466880; PMCID: PMC2577821.
    80. Carter C, van Veen V. Anterior cingulate cortex and conflict detection: an update of theory and data. Cogn Affect Behav Neurosci. 2007 Dec; 7(4):367-79. PMID: 18189010.
      View in: PubMed
    81. Salo R, Nordahl TE, Leamon MH, Natsuaki Y, Moore CD, Waters C, Carter C. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res. 2008 Jan 15; 157(1-3):273-7. PMID: 17928066.
      View in: PubMed
    82. Carter C. Some rewarding insights into the cognitive and neurobiological basis of negative symptoms in schizophrenia. Biol Psychiatry. 2007 Oct 01; 62(7):709-10. PMID: 17854580.
      View in: PubMed
    83. Minzenberg MJ, Carter C. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008 Jun; 33(7):1477-502. PMID: 17712350.
      View in: PubMed
    84. Minzenberg MJ, Carter C. The quest for developing new treatments from imaging techniques: promises, problems and future potential. Expert Opin Drug Discov. 2007 Aug; 2(8):1029-33. PMID: 23484869.
      View in: PubMed
    85. Ravizza SM, Robertson LC, Carter C, Nordahl TE, Salo RE. Is filtering difficulty the basis of attentional deficits in schizophrenia? Psychiatry Res. 2007 Jun 30; 151(3):201-9. PMID: 17399801.
      View in: PubMed
    86. Yoon JH, D'Esposito M, Carter C. Preserved function of the fusiform face area in schizophrenia as revealed by fMRI. Psychiatry Res. 2006 Dec 01; 148(2-3):205-16. PMID: 17095198.
      View in: PubMed
    87. Kerns JG, Cohen JD, MacDonald AW, Johnson MK, Stenger VA, Aizenstein H, Carter C. Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia. Am J Psychiatry. 2005 Oct; 162(10):1833-9. PMID: 16199829.
      View in: PubMed
    88. Carter C. Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophr Bull. 2005 Oct; 31(4):810-5. PMID: 16107584.
      View in: PubMed
    89. Ursu S, Carter C. Outcome representations, counterfactual comparisons and the human orbitofrontal cortex: implications for neuroimaging studies of decision-making. Brain Res Cogn Brain Res. 2005 Apr; 23(1):51-60. PMID: 15795133.
      View in: PubMed